Robert Flaumenhaft

10.3k total citations · 1 hit paper
161 papers, 7.7k citations indexed

About

Robert Flaumenhaft is a scholar working on Hematology, Cell Biology and Molecular Biology. According to data from OpenAlex, Robert Flaumenhaft has authored 161 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Hematology, 54 papers in Cell Biology and 44 papers in Molecular Biology. Recurrent topics in Robert Flaumenhaft's work include Platelet Disorders and Treatments (55 papers), Endoplasmic Reticulum Stress and Disease (34 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). Robert Flaumenhaft is often cited by papers focused on Platelet Disorders and Treatments (55 papers), Endoplasmic Reticulum Stress and Disease (34 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). Robert Flaumenhaft collaborates with scholars based in United States, China and Israel. Robert Flaumenhaft's co-authors include Price Blair, Daniel B. Rifkin, Bruce Furie, Joseph E. Italiano, David Moscatelli, Barbara C. Furie, James R. Dilks, Albert T.A. Mairuhu, Mayumi Abé and Karen De Ceunynck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Robert Flaumenhaft

155 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Platelet α-granules: Basic biology and clinical correlates

2009 842 citations Robert Flaumenhaft et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Flaumenhaft United States	49	2.7k	2.4k	1.5k	1.1k	979	161	7.7k
Tatiana V. Byzova United States	50	4.2k 1.5×	1.4k 0.6×	1.2k 0.8×	1.4k 1.2×	738 0.8×	124	8.9k
Perumal Thiagarajan United States	43	2.9k 1.1×	2.7k 1.1×	371 0.2×	1.2k 1.1×	1.0k 1.0×	138	7.5k
Michael J. Barnes United Kingdom	48	2.1k 0.8×	2.5k 1.0×	931 0.6×	1.1k 1.0×	853 0.9×	118	8.3k
Matthew J. Flick United States	41	1.8k 0.7×	2.3k 0.9×	359 0.2×	932 0.8×	1.4k 1.5×	120	7.2k
Anton Jan van Zonneveld Netherlands	57	5.0k 1.8×	1.9k 0.8×	540 0.4×	1.1k 1.0×	1.1k 1.1×	211	10.6k
Pieter Koolwijk Netherlands	42	2.8k 1.0×	832 0.3×	519 0.3×	776 0.7×	713 0.7×	126	6.8k
Jerry Ware United States	50	2.0k 0.7×	5.2k 2.1×	405 0.3×	1.4k 1.3×	1.1k 1.1×	148	8.4k
Bruce A. Keyt United States	31	5.1k 1.9×	1.7k 0.7×	446 0.3×	599 0.5×	727 0.7×	79	9.9k
Yoshihisa Nojima Japan	40	2.2k 0.8×	972 0.4×	463 0.3×	1.6k 1.4×	514 0.5×	231	6.1k
Claudine Soria France	50	2.5k 0.9×	2.1k 0.9×	506 0.3×	572 0.5×	1.8k 1.8×	212	7.8k

Countries citing papers authored by Robert Flaumenhaft

Since Specialization

Citations

This map shows the geographic impact of Robert Flaumenhaft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Flaumenhaft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Flaumenhaft more than expected).

Fields of papers citing papers by Robert Flaumenhaft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Flaumenhaft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Flaumenhaft. The network helps show where Robert Flaumenhaft may publish in the future.

Co-authorship network of co-authors of Robert Flaumenhaft

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Flaumenhaft. A scholar is included among the top collaborators of Robert Flaumenhaft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Flaumenhaft. Robert Flaumenhaft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Wanjun, et al.. (2025). Molecular Insights into the Dual Mechanism of Bepristat 2a on Protein Disulfide Isomerase (PDI) Activity. The Journal of Physical Chemistry Letters. 16(45). 11861–11866.

Yang, Moua, Anika Patel, Glenn Merrill‐Skoloff, et al.. (2025). Galloylated polyphenols represent a new class of antithrombotic agents with broad activity against thiol isomerases. Journal of Thrombosis and Haemostasis. 23(6). 1850–1863. 1 indexed citations

Kumar, Suresh, et al.. (2024). Cryo-EM structure and functional basis of prothrombin recognition by a type I antiprothrombin antiphospholipid antibody. Blood. 143(19). 2005–2011. 2 indexed citations

Becker, Isabelle C., Virginia Camacho, María N. Barrachina, et al.. (2024). Targeting cargo to an unconventional secretory system within megakaryocytes allows the release of transgenic proteins from platelets. Journal of Thrombosis and Haemostasis. 22(11). 3235–3248. 4 indexed citations

Yang, Moua, Lin Lin, & Robert Flaumenhaft. (2024). Protocol to identify flavonoid antagonists of the SARS-CoV-2 main protease. STAR Protocols. 5(2). 102990–102990.

Yang, Moua, Anika Patel, Da‐Yuan Chen, et al.. (2023). Galloylated Polyphenols Represent a New Class of Antithrombotic Antagonists of Thiol Isomerases. Blood. 142(Supplement 1). 684–684. 3 indexed citations

Ji, Panpan, Xueying Chen, Yang Zhou, et al.. (2023). Enhanced inhibition of protein disulfide isomerase and anti-thrombotic activity of a rutin derivative: rutin:Zn complex. RSC Advances. 13(17). 11464–11471. 8 indexed citations

Patell, Rushad, Christian Peters, Moua Yang, et al.. (2023). The unfolded protein response links ER stress to cancer-associated thrombosis. JCI Insight. 8(19). 5 indexed citations

Schmaier, Alec A., et al.. (2023). TMEM16E regulates endothelial cell procoagulant activity and thrombosis. Journal of Clinical Investigation. 133(11). 22 indexed citations

10.

Li, Jinyu, et al.. (2022). Flavonoids as Protein Disulfide Isomerase Inhibitors: Key Molecular and Structural Features for the Interaction. Journal of Agricultural and Food Chemistry. 70(14). 4475–4483. 14 indexed citations

11.

Merrill‐Skoloff, Glenn, Karen De Ceunynck, James R. Dilks, et al.. (2021). The secreted tyrosine kinase VLK is essential for normal platelet activation and thrombus formation. Blood. 139(1). 104–117. 6 indexed citations

12.

Sharda, Anish V., et al.. (2021). Circulating Protein Disulfide Isomerase Is Associated with Increased Risk of Thrombosis in JAK2 -Mutated Myeloproliferative Neoplasms. Clinical Cancer Research. 27(20). 5708–5717. 14 indexed citations

13.

Yang, Moua & Robert Flaumenhaft. (2021). Oxidative Cysteine Modification of Thiol Isomerases in Thrombotic Disease: A Hypothesis. Antioxidants and Redox Signaling. 35(13). 1134–1155. 13 indexed citations

14.

Schmaier, Alec A., Zachary Manickas-Hill, Anjali K. Nath, et al.. (2021). Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19. JCI Insight. 6(20). 41 indexed citations

15.

Yang, Moua, Wei Li, Wenjing Chen, et al.. (2020). Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia. Blood Advances. 4(18). 4494–4507. 26 indexed citations

16.

Matsuura, Shinobu, Mostafa Belghasem, Orly Leiva, et al.. (2020). Platelet Dysfunction and Thrombosis in JAK2 ^V617F -Mutated Primary Myelofibrotic Mice. Arteriosclerosis Thrombosis and Vascular Biology. 40(10). e262–e272. 33 indexed citations

17.

Wang, Xu, Guangpu Xue, Meiru Song, et al.. (2018). Molecular basis of rutin inhibition of protein disulfide isomerase (PDI) by combinedin silicoand experimental methods. RSC Advances. 8(33). 18480–18491. 17 indexed citations

18.

Flaumenhaft, Robert, Nataliya Rozenvayn, Dian Feng, & Ann M. Dvořàk. (2007). SNAP-23 and syntaxin-2 localize to the extracellular surface of the platelet plasma membrane. Blood. 110(5). 1492–1501. 15 indexed citations

19.

Sim, Derek, James R. Dilks, & Robert Flaumenhaft. (2007). Platelets Possess and Require an Active Protein Palmitoylation Pathway for Agonist-Mediated Activation and In Vivo Thrombus Formation. Arteriosclerosis Thrombosis and Vascular Biology. 27(6). 1478–1485. 32 indexed citations

20.

Flaumenhaft, Robert, Soichi Kojima, Mayumi Abé, & Daniel B. Rifkin. (1993). Activation of Latent Transforming Growth Factor ß. Advances in pharmacology. 24. 51–76. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact